Metallizing Engineering v. Kenyon Bearing: Secret Commercial Use Forfeits the Patent

Judge Learned Hand held that an inventor who commercially exploits an invention in secret beyond the grace period forfeits the right to patent it, forcing a choice between trade-secret protection and the patent monopoly.

Sparks flying as a worker grinds and sprays metal in an industrial machine shop
The invention was a secret process for reconditioning worn metal parts by spraying molten metal onto them. Shutterstock
Educational content, not legal advice. This article explains general legal concepts. It does not create an attorney–client relationship. For your specific situation, consult a licensed attorney.

Metallizing Engineering Co. v. Kenyon Bearing & Auto Parts Co., 153 F.2d 516 (2d Cir. 1946), is Judge Learned Hand’s canonical statement of the “secret commercial use” forfeiture rule — the principle that an inventor who exploits an invention commercially in secret, for longer than the statutory grace period, loses the right to patent it. The invention was a process for reconditioning worn metal parts by spraying molten metal onto them, which the inventor had quietly used to serve paying customers for years before filing his application. Hand held that this secret commercial exploitation forfeited the patent, even though the public learned nothing of the process. The decision draws one of trade-secret law’s sharpest strategic lines: an inventor must choose between the concealment of a trade secret and the disclosure-for-monopoly bargain of a patent, and cannot enjoy the profits of secrecy first and the patent term afterward.

At a glance

  • Case: Metallizing Engineering Co. v. Kenyon Bearing & Auto Parts Co., 153 F.2d 516 (2d Cir. 1946)
  • Court: U.S. Court of Appeals for the Second Circuit (panel of L. Hand, A. N. Hand, and Clark, JJ.)
  • Decided: January 1946
  • Opinion: Judge Learned Hand for the court
  • Subject matter: Whether an inventor’s prior secret commercial use of a process forfeits his right to a patent under the statutory “public use” bar
  • Holding: An inventor who competitively exploits an invention in secret for more than the grace period before filing forfeits the right to a patent, regardless of how little the public learned

The secret metallizing process

The invention concerned “metallizing” — a technique for building up and reconditioning worn metal surfaces by spraying them with molten metal. The inventor, Meduna, developed a process for preparing the surface so the sprayed metal would adhere properly, and he put it to work commercially, using it to recondition parts for customers as a paying service. He kept the details of the process secret rather than publishing them, and he continued this secret commercial exploitation well before he sought patent protection. The application that matured into the patent in suit was filed on August 6, 1942, so the critical statutory date fell one year earlier, on August 6, 1941. The record showed that Meduna had used the process commercially, in secret, before that date.

When Metallizing Engineering (the patent owner through Meduna) sued Kenyon Bearing for infringement, Kenyon defended on the ground that the patent was invalid: the invention had been in “public use” more than a year before the application, contrary to the statutory bar. The twist was that the use had not been public at all in any ordinary sense — it was a closely held trade-secret operation. The question for Hand was whether an inventor’s secret commercial use of his own invention could nonetheless trigger the “public use” bar and defeat the patent.

Learned Hand’s forfeiture principle

Hand answered yes, and in doing so he distinguished two lines of authority that had long seemed to sit in tension. One line held that a third party’s prior secret use of an invention does not invalidate a later patent obtained by an independent inventor, because a use that teaches the public nothing cannot be a “public use” that forecloses patenting. The other line — reaching back to nineteenth-century decisions — held that an inventor forfeits his own right to a patent if he exploits the invention commercially before filing. Hand reconciled them by locating the difference not in the secrecy of the use but in whose use it was.

The governing distinction, Hand explained, turns on the identity of the user. When a stranger secretly practices an invention, that use does not bar a later, independent inventor from patenting, because the statutory bar exists to keep the public’s stock of knowledge free, not to punish someone who had nothing to do with the concealment. But when the inventor himself commercially exploits his invention in secret and then, after reaping those profits, seeks a patent, he has attempted to extend his period of exclusivity beyond what the law allows. In Hand’s famous formulation, “it is a condition upon an inventor’s right to a patent that he shall not exploit his discovery competitively after it is ready for patenting; he must content himself with either secrecy, or legal monopoly.” Because Meduna had gone beyond the permitted grace period of secret commercial use, he “forfeited his right regardless of how little the public may have learned about the invention.” The patent was therefore invalid.

Secrecy or monopoly, but not both in sequence

The deep logic of the opinion is a policy against double-dipping in the patent bargain. A patent is a quid pro quo: the public grants a limited term of exclusivity in exchange for the inventor’s disclosure of how the invention works, so that when the term ends the invention passes into the public domain. An inventor who commercializes in secret already enjoys a de facto exclusivity — competitors cannot copy what they cannot see — and if he could later obtain a patent, he would effectively tack a full patent term onto the head start he already banked in secrecy, prolonging his monopoly beyond the statutory grant. Hand’s rule forecloses that maneuver by making commercial exploitation “ready for patenting” the moment the clock begins to run for the inventor.

Crucially, the forfeiture is personal to the inventor and is not defeated by the secrecy of the use — precisely the opposite of the rule for strangers. This asymmetry is the feature students of the doctrine most often stumble over, and it is the point Hand drew most carefully. The consequence for planning is stark: an inventor cannot hedge by treating a commercially deployed invention as a trade secret indefinitely while preserving the option to patent it later. Once the invention is ready for patenting and the inventor begins to profit from it in secret, the grace period is the entire window; let it lapse, and the patent door closes for good, leaving trade-secret protection — with all its fragility — as the only remaining shelter.

Open questions

Metallizing set the rule but not every boundary. What exactly counts as commercial exploitation “ready for patenting,” as opposed to experimental use that does not start the clock, remains a recurring battleground. The doctrine has also had to be reconciled with statutory change. The Leahy-Smith America Invents Act rewrote the on-sale and public-use bars, prompting arguments that secret commercialization might no longer count — but in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., 586 U.S. 123 (2019), the Supreme Court held that even a confidential, secret sale can trigger the AIA’s on-sale bar, preserving the core of Hand’s insight that secret commercial activity can defeat patentability. How completely the forfeiture principle survives in every corner of the post-AIA landscape continues to be litigated, but its strategic thrust endures.

Implications

  • Choose your protection early. An inventor must elect between trade-secret secrecy and the patent monopoly; commercial exploitation in secret beyond the grace period forfeits the ability to patent the same invention later.
  • The bar is personal to the inventor. Secret commercial use by the inventor forfeits the patent, but the same secret use by an unrelated third party generally will not bar an independent inventor’s later patent — the outcome turns on who used the invention.
  • Secrecy does not save you. Forfeiture applies “regardless of how little the public may have learned”; keeping the process confidential is exactly what makes the head start impermissible when the inventor later seeks a patent.
  • The lesson outlived the statute. After the America Invents Act and Helsinn, secret and confidential commercial sales can still trigger the on-sale bar, so the plan-early imperative of Metallizing remains sound advice.

Frequently asked questions

What is the Metallizing forfeiture rule? An inventor who commercially exploits an invention in secret for more than the statutory grace period before filing a patent application forfeits the right to a patent. Judge Learned Hand held that the inventor must choose: keep the invention as a trade secret, or seek the patent monopoly, but not first profit in secrecy and then patent to extend protection.

How is secret use by the inventor different from secret use by someone else? The distinction is who is using the invention. Prior secret commercial use by a third party generally does not invalidate a later patent, because it does not inform the public. But secret commercial exploitation by the inventor himself triggers forfeiture — the bar is personal to the inventor as a condition of the patent right.

Does Metallizing still matter after the America Invents Act? Yes. Courts continue to apply the forfeiture principle, and the Supreme Court’s 2019 decision in Helsinn v. Teva confirmed that even secret or confidential commercial sales can trigger the on-sale bar under the AIA. The strategic lesson endures: you cannot commercialize in secret indefinitely and then patent to reset the clock.

Authorities and sources

  • Metallizing Engineering Co. v. Kenyon Bearing & Auto Parts Co., 153 F.2d 516 (2d Cir. 1946). Justia; Casebriefs summary.
  • Doctrinal critique and history in Did Learned Hand Get It Wrong?: The Questionable Patent Forfeiture Rule of Metallizing Engineering (Villanova Law Review) — full text PDF.
  • Modern on-sale-bar treatment in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., 586 U.S. 123 (2019) — Justia.

Related guides

Lidiia Levitska
About the Author

Lidiia Levitska

International Intellectual Property Attorney

Lidiia Levitska focuses on intellectual property dispute resolution, policy, and advisory work across international institutions and government bodies. From 2021 to 2025 she served at the World Intellectual Property Organization (WIPO), managing arbitration cases and overseeing compliance with the Uniform Domain-Name Dispute-Resolution Policy (UDRP), and earlier led IP policy research as a Senior Policy Officer at the American Chamber of Commerce in Ukraine. She holds an LL.M. in International Intellectual Property Law from Chicago-Kent College of Law and an M.A. in Information Technology Law from the University of Tartu, and was admitted to the Ukrainian Bar in 2019.

More about Lidiia →